Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiologic mechanisms in acquired aplastic anemia.

Neal S Young1

  • 1Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20891, USA. youngns@mail.nih.gov

Hematology. American Society of Hematology. Education Program
|November 25, 2006
PubMed
Summary

Aplastic anemia, a bone marrow failure syndrome, involves immune system attacks on hematopoietic stem cells. Genetic mutations affecting telomere repair also contribute to this rare hematologic disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia.

NEJM evidence·2026
Same author

Imputing causality and clonal dynamics from single-cell transcriptomics in paroxysmal nocturnal hemoglobinuria.

Leukemia·2026
Same author

Selective Janus kinase inhibitors exhibit different effects in murine immune aplastic anemia.

HemaSphere·2026
Same author

T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function.

Frontiers in immunology·2026
Same author

Reframing-renaming(?)-myelodysplastic syndromes/neoplasms and clonal hematopoiesis of indeterminate potential.

Leukemia·2026
Same author

STAT3 SH2 Domain Aspartic Acid 661 Mutations Activate Immune Gene Programs.

Journal of cellular and molecular medicine·2026

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Aplastic anemia is a rare hematologic disorder characterized by bone marrow failure.
  • Its immune pathophysiology is suggested by patient responses to immunosuppressive therapy.
  • Understanding the molecular basis of T cell responses and stem cell defects is crucial.

Purpose of the Study:

  • To identify the molecular mechanisms underlying T cell-mediated damage in aplastic anemia.
  • To investigate the genetic causes of hematopoietic stem cell depletion in aplastic anemia.
  • To elucidate the role of telomere repair in the pathogenesis of acquired aplastic anemia.

Main Methods:

  • Cell culture experiments implicating activated type 1 cytotoxic T cells and cytokines.
  • Analysis of cytokine gene polymorphisms and gamma-interferon regulatory pathways.

Related Experiment Videos

  • Genetic analysis of telomere repair complex genes in patients with aplastic anemia.

    • Main Results:

    • Activated type 1 cytotoxic T cells and type 1 cytokines are implicated in aplastic anemia pathogenesis.
    • Cytokine gene polymorphisms and aberrant gamma-interferon regulation contribute to the immune response.
    • Mutations in telomere repair genes are found in some aplastic anemia patients, leading to telomere shortening and reduced progenitor cells.

    Conclusions:

    • Aplastic anemia involves both immune-mediated destruction of hematopoietic stem cells and genetic factors affecting stem cell integrity.
    • Telomerase deficiency and associated telomere shortening play a role in stem cell depletion in some cases.
    • Further research into these molecular mechanisms can inform therapeutic strategies for aplastic anemia.